MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...

and build a connected system based around an automated insulin delivery device and connected pen. Evidation has also been working with Eli Lilly's rival in diabetes, Sanofi, in a partnership along ...

Sanofi's rash of dealmaking has continued with a $2.5 billion tie-up with Chinese cancer immunotherapy biotech Adagene, focused on developing a new generation of safer antibody-based therapies.